Previous 10 | Next 10 |
TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that it has received Japanese regulatory approval for the Senhance™ Surgical System. “Reg...
SIMPLIFYING RECENT INNOVATON ANNOUNCEMENTS AT HRS IN TERMS OF REVENUE AND PROFITABLITY; STRONG POTENTIAL OUTLOOK WITH OVER $60 MILLION IN SALES AND LARGE PROFITS FROM JUST EXISTING CUSTOMER BASE Stereotaxis is a global pioneer and leader of robotics for endovascular surgery with a fantasti...
CymaBay Therapeutics (NASDAQ: CBAY ) initiated with Buy rating and $21 (70% upside) price target at Citigroup. Shares up 1% premarket. More news on: CymaBay Therapeutics, Inc., MannKind Corporation, Pieris Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , ...
Gainers: Charles & Colvard (NASDAQ: CTHR ) +34% . Buckeye Partners (NYSE: BPL ) +28% . Cardlytics (NASDAQ: CDLX ) +26% . G1 Therapeutics (NASDAQ: GTHX ) +24% . Westport Fuel Systems (NASDAQ: WPRT ) +21% . Cool Holdings (NASDAQ: AWSM ) +22% . Guardant Health (NASDAQ: GH ) +...
Puma Biotechnology (NASDAQ: PBYI ) -35% on Q1 earnings . More news on: Puma Biotechnology, Inc., TransEnterix, Inc., Verastem, Inc., Stocks on the move, Read more ...
TransEnterix, Inc. (TRXC) Q1 2019 Results Conference Call May 09, 2019 04:30 PM ET Company Participants Mark Klausner - Investor Relations Todd Pope - President and Chief Executive Officer Joe Slattery - Executive Vice President and Chief Financial Officer Conference Call Part...
"We were disappointed with our results in the first quarter," says CEO Todd Pope, though he notes "solid progress" towards the expansion of the company's global sales infrastructure and the development of the U.S. installed base. More news on: TransEnterix, Inc., Healthcare stocks news, St...
TransEnterix (NYSEMKT: TRXC ): Q1 Non-GAAP EPS of -$0.09 misses by $0.01 ; GAAP EPS of -$0.10 misses by $0.01 . Revenue of $2.18M (-54.3% Y/Y) misses by $3.62M . Shares -15.2% . Press Release More news on: TransEnterix, Inc., Earnings news and commentary, Healthcare stocks news...
TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the first quarter of 2019. Recent Highlights Total...
AAXN , AGO , AIRG , AL , ALRM , ALTR , AMBC , AMBR , AMPH , AQN , ASYS , BGNE , BKNG , CABO , CARG , CISN , CORT , CTRL , CUTR , DBX , EFX , ELY , EQH , FGEN , FLY , FSCT , GH , GLOB , GPRO , GSBD , ICUI , JAG , MAIN , MAXR , MTD , MTW , NDLS , NTR , N...
News, Short Squeeze, Breakout and More Instantly...
Asensus Surgical , Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release fourth quarter ...
Are These Penny Stocks Set To Bounce With The Market? As we move further into March, many penny stocks are continuing to climb. But it hasn’t come without some headwinds from the broader markets. While February didn’t close on a high note, March is getting off to an in...